SLC22A24 Antibody, FITC conjugated
-
中文名稱：SLC22A24兔多克隆抗體, FITC偶聯
-
貨號：CSB-PA850799LC01HU
-
規格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) SLC22A24 Polyclonal antibody
-
Uniprot No.：
-
基因名：SLC22A24
-
別名：SLC22A24; Steroid transmembrane transporter SLC22A24; Solute carrier family 22 member 24
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Solute carrier family 22 member 24 protein (37-145AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：FITC
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Steroid transmembrane transporter that functions in the reabsorption of conjugated steroids in the kidney and is involved in steroid homeostasis.; Similar uptake function as Isoform 1.; Lack of transporter activity.
-
亞細胞定位：[Isoform 1]: Membrane; Multi-pass membrane protein.; [Isoform 2]: Membrane; Multi-pass membrane protein.
-
蛋白家族：Major facilitator (TC 2.A.1) superfamily, Organic cation transporter (TC 2.A.1.19) family
-
組織特異性：[Isoform 1]: Localized to the kidney. Highly specific expression pattern in the nephron, localized to segment 3 of the proximal tubule.; [Isoform 2]: Localized to the kidney. Highly specific expression pattern in the nephron, localized to segment 3 of the
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
